Refractory Triple-Negative Breast Carcinoma trials recruiting in New York

Fewer than 3 recruiting trials found.

All Refractory Triple-Negative Breast Carcinoma trials nationally

1

Recruiting in New York

1

Cities with sites

Cities in New York

Buffalo 1

Recruiting trials in New York

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
NCT05741164 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · New York: Buffalo

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.